Emek medical center
Afula, Israel
NCT Number: NCT02953002
In total 200 subjects with diagnosis of sepsis, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). Sequential Organ Failure Assessment score SOFA will be calculated. The relation between SOFA score and thrombin measurements will be determined.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Afula, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Calibrated Automated Thrombogram (CAT). Thrombogram describes the concentration of thrombin in clotting plasma and is therefore a general physiologic function test of the thrombotic hemostatic system. The CAT measures thrombotic as well as bleeding tendency.
Time frame: one week
HaEmek Medical Center, Israel
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07576621
Cardiovascular Diseases, Coagulopathy
Cairo, Egypt
View Trial DetailsNCT07404475
Cardiovascular Diseases, Coagulopathy
Ancona, Italy
View Trial DetailsNCT06854640
Blood Coagulation Disorders, Cardiovascular Diseases
Edegem, Belgium
View Trial DetailsNCT03095625
Bleeding Disorder, Cardiovascular Diseases
Turin, Piedmont, Italy
View Trial Details